PFM Health Sciences’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-793,951
| Closed | -$23.7M | – | 115 |
|
|
2018
Q1 | $23.7M | Buy |
793,951
+24,156
| +3% | +$721K | 0.48% | 62 |
|
|
2017
Q4 | $25.6M | Buy |
+769,795
| New | +$25.6M | 0.61% | 55 |
|
|
2017
Q3 | – | Sell |
-271,603
| Closed | -$5.36M | – | 96 |
|
|
2017
Q2 | $5.36M | Sell |
271,603
-526,644
| -66% | -$10.4M | 0.14% | 79 |
|
|
2017
Q1 | $15.4M | Buy |
798,247
+299,662
| +60% | +$5.78M | 0.39% | 68 |
|
|
2016
Q4 | $9.25M | Buy |
498,585
+211,346
| +74% | +$3.92M | 0.26% | 74 |
|
|
2016
Q3 | $4.02M | Buy |
+287,239
| New | +$4.02M | 0.12% | 77 |
|
|
2016
Q1 | – | Sell |
-119,092
| Closed | -$1.98M | – | 86 |
|
|
2015
Q4 | $1.98M | Buy |
119,092
+11,787
| +11% | +$196K | 0.06% | 64 |
|
|
2015
Q3 | $2.36M | Buy |
+107,305
| New | +$2.36M | 0.07% | 62 |
|